In the mobile medical industry, only companies that find a breakthrough point in profit can successfully survive the harsh "capital winter."
In the past three years, the mobile medical industry has experienced a “blowout†growth. Relevant data show that the scale of China's mobile medical market in 2014 was about 2.95 billion yuan; in 2015, it increased by 44.7% to 4.27 billion yuan; it is expected to reach 12.08 billion yuan in 2017. In terms of user scale, the number of mobile medical users in China reached 72 million in 2014, and it increased to 138 million in 2015.
At the same time, Boston Consulting also gave a corresponding assessment of China Mobile's medical industry. According to its forecast, by 2020, China's digital medical market will reach 700 billion yuan. In the first half of 2015, the total amount of domestic mobile medical ventures was nearly 800 million US dollars, exceeding the total of 4.5 billion yuan in 2014. The number of mobile medical platforms nationwide exceeded 2,000.
Although the "cake" of the mobile medical industry has been estimated to be large, according to the reporter's summary, the high growth is also facing the "winter winter" situation.
It is understood that at the end of 2015, the mobile medical industry presented many problems such as money-burning subsidies, vicious bills, and data fraud. Affected by this, most mobile medical APP only got the angel round or A round of financing, only 50 more than the B round, only 10 more into the C round, the "curse" of "C round death" also Step by step.
In April 2016, a "Mobile Medical Company's latest death list" further aggravated the industry panic, and 27 small and famous mobile medical companies declared "death." In May, the first drug delivery O2O company that received the A round of financing failed to finance successfully and was forced to leave.
Different from other industries, the medical industry has the characteristics of “three highs†with high professionalism, high monopoly and high policy risk. The current high valuation of the mobile medical industry can only be seen from afar. A number of investors told reporters that if mobile medical care cannot solve the pain points of traditional medical care, its social and commercial value will be difficult to reflect.
However, within the mobile healthcare industry, there are also cases of seeking breakthroughs by constantly looking for profit points.
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com